Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma

American Journal of Roentgenology

Volumn 192, Issue 3, 2009, Pages 698-705

  Inoue, Tatsuo ^a   Kudo, Masatoshi ^a   Maenishi, Osamu ^a   Komuta, Mina ^b   Nakashima, Osamu ^b   Kojiro, Masamichi ^b   Maekawa, Kiyoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cirrhotic liver; Contrast enhanced sonography; Dysplastic nodules; Hepatocellular carcinoma; Kupffer cells; Liver parenchymal phase imaging

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYSACCHARIDES; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 63049092043     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3282     Document Type: Article

References (20)

1. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24:807-812
2. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent-preliminary results. Radiology 1998; 209: 135-140
3. Kudo M. Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62:48-56
4. Kudo M. Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors. Tokyo, Japan: Springer-Verlag, 2003
5. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297-309
6. Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR 2004; 182:1019-1026 [Erratum in AJR 2004; 183:1175]
7. Pugh RNH, Murray-Lyon IM, Dawson JL, Pi- etroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-669
8. [No authors listed]. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995; 22:983-993
9. Albrecht T, Hoffmann CW, Schettler S, Overberg A, Ilg M, Wolf KJ. Improved detection of liver metastases with phase inversion imaging during the liver-specific phase of the ultrasound contrast agent, Levovist. Eur Radiol 1999; 9[suppl 3]: S388
10. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14:1092-1099
11. Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast- enhanced US: comparison with histologic differentiation. Radiology 2007; 244:898-906
12. Bauer A, Blomley M, Leen E, Cosgrove D, Schlief R. Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 1999; 9[suppl 3]:S349- S352
13. Marelli C. Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection. Eur Radiol 1999; 9[suppl 3]:S343-S346
14. Kono Y, Gregory CS, Thomas P, et al. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intra- vital microscopy study in rats. Radiology 2002;224:253-257
15. Bouwens L, Baekeland M, De Zanger R, Wisse E. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepa-tology 1986; 6:718-722
16. Ruttinger D, Vollmar B, Wanner GA, et al. In vivo assessment of hepatic alterations following chloride-induced Kupffer cell blockade. J Hepatol 1996; 25:960-967
17. Sugihara S, Kojiro M, Nakashima T. Ultrastruc-tural study of hepatocellular carcinoma with replacing growth pattern. Acta Pathol Jpn 1985;35:549-559
18. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascu- lar hepatocellular carcinoma: correlation with in- tranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002; 225:143-149
19. Kudo M, Okanoue T; Japan Society of Hepatolo-gy. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72[suppl 1]:2-15
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236